Added benefit of lisdexamfetamine is not proven

Administration without forming part of comprehensive treatment program -- study duration too short

2013-09-03

(Press-News.org) Lisdexamfetamine dimesylate (trade name: Elvanse) has been approved in Germany since March 2013 as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (ADHD) in children aged 6 years and over when response to previous treatment with the drug methylphenidate was inadequate. No added benefit of the drug versus the appropriate comparator therapy could be established in the assessment of the drug manufacturer's dossier according to the Act on the Reform of the Market for Medicinal Products (AMNOG). The manufacturer did not present any relevant studies. This was the result of the report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) on 2 September 2013.

Medication only as part of a comprehensive treatment programme

Both lisdexamfetamine (short for lisdexamfetamine dimesylate) and the appropriate comparator therapy specified by the Federal Joint Committee (G-BA) atomoxetine are approved for administration as part of a comprehensive treatment programme (multimodal treatment for ADHD). According to the Summaries of Product Characteristics (SPC) of these drugs, a comprehensive treatment programme typically includes psychological, educational and social measures. The SPC of lisdexamfetamine additionally regards appropriate educational placement as "essential" and psychosocial intervention as "generally necessary".

Moreover, according to the G-BA's Pharmaceutical Directive, both drugs as stimulants in ADHD can only be prescribed at all as part of a comprehensive treatment programme for the treatment of ADHD.

In agreement with the G-BA, the manufacturer cited atomoxetine as appropriate comparator therapy, but did not present any relevant studies for the comparison with lisdexamfetamine.

ADHD drugs were not used in compliance with their approval

In the only study presented (SPD489-317), lisdexamfetamine and atomoxetine were only seen as drug treatment – without being part of a comprehensive treatment programme. This was neither sensible nor did it comply with the approval, and therefore did also not cover the appropriate comparator therapy.

There was no offer of psychological, educational or social measures, for example. There was also no consultation for the children (and parents) to adapt measures or take on other, more suitable measures, if necessary.

Moreover, it was only possible to a limited extent to continue previous ongoing non-drug treatment in the study: Only 8% of the children and adolescents continued receiving non-drug treatment. Only 22% of the study participants in total had received a non-drug treatment of ADHD before anyway.

Short-term study insufficient

ADHD is a chronic disease for which drug treatment over a longer period of time may be necessary according to the SPC of lisdexamfetamine. The study SPD489-317 had a treatment duration of 9 weeks in total and was therefore also too short to draw conclusions on an added benefit.

Hence there were several reasons why the study presented by the manufacturer was unsuitable. An added benefit of lisdexamfetamine is therefore not proven.

G-BA decides on the extent of added benefit

The dossier assessment is part of the overall procedure for early benefit assessments supervised by the G-BA. After publication of the manufacturer's dossier and IQWiG's assessment, the G-BA conducts a commenting procedure, which may provide further information and result in a change to the benefit assessment. The G BA then decides on the extent of the added benefit, thus completing the early benefit assessment.

### An overview of the results of IQWiG's benefit assessment is given by a German-language executive summary. In addition, the website » http://www.gesundheitsinformation.de, published by IQWiG, provides easily understandable and brief German-language information on lisdexamfetamine dimesylate.

The G-BA website contains both general English-language information on benefit assessment pursuant to §35a Social Code Book V and specific German-language information on the assessment of lisdexamfetamine dimesylate. More English-language information will be available soon (Sections 2.1 to 2.6 of the dossier assessment as well as subsequently published health information on » http://www.informedhealthonline.org).

If you would like to be informed when these documents are available, please send an e-mail to » info@iqwig.de.

ELSE PRESS RELEASES FROM THIS DATE:

Level playing field for Clostridium difficile diagnosis

2013-09-03

The largest study of its kind has shown the most effective test for the diagnosis of Clostridium difficile (C-Diff), a bacterial infection which causes 15,000-20,000 deaths a year in hospitals in the United States. C-Diff affects the digestive system, and is most common in hospital patients treated with antibiotics for other infections. The multi-centre study, carried out by UK researchers at the University of Leeds, in partnership with colleagues from the University of Oxford, University College London and St George's, University of London, tested more than 12,000 ...

Recommendations for removing copyright hurdles to scientific research

2013-09-03

The EU e-infrastructure coordination pro-iBiosphere project is preparing the ground for the pursuit of biological research in the digital age. In its "Draft policy for Open Access to data and information" scientists and lawyers recommend that hurdles posed by copyright and database protection should be removed by establishing exceptions for research in a new binding, Europe-wide regulation. This report opens a consultation process that will last until December 2013. Input is welcomed on pro-iBiosphere's Google+ , LinkedIn or Facebook. At present, national provisions ...

Recommendations on how to move the naming of organisms from paper and on to the Internet

2013-09-03

"Well, I suppose I'd better start finding names for things…" was the first thing said by the ill-fated sperm whale (Physeter macrocephalus Linnaeus, 1758) in Douglas Adam's Hitchhikers Guide to the Galaxy. Such is the richness of life that, unlike that whale, mankind is still naming things. Without commonly accepted names there would be no way to communicate research about life and it is the profession of taxonomists to put names on organisms and describe the different forms of life on Earth. The EU e-Infrastructure coordination project "pro-iBiosphere", targeting the ...

The future of biodiversity publishing

2013-09-03

The traditional audience for books and scientific papers in which scientists report their findings has been the human reader. Now we can enhance publications by attaching to them many different kinds of digital objects (such as the sounds made by birds, maps that show where they occur, or images and videos) or by adding computer-readable sections and terms that allow computers to extract information for re-use. We refer to these enriched and marked-up documents as 'enhanced'. While the technology is available, only a tiny proportion of scientific publications are enhanced. ...

Rim Fire update Sept. 02, 2013

2013-09-03

The Rim Fire in and around Yosemite National Park, which began on August 17, 2013 is now the fourth largest fire in California's history. According to Inciweb.org for Sept. 02, 2013: "The Rim Fire grew approximately 8,310 acres, to a total size of 231,088 acres. Burnout operations on the northern and southern portions of the fire continued with success through the night. Southwest transport winds returned smoke to the communities northeast of the fire, including Reno, Carson City, Markleeville, Minden, and the Lake Tahoe Basin, and returned clearer skies to the Yosemite ...

Action-inaction balance in cultural values more common in East Asian countries

2013-09-03

PHILADELPHIA -- People in East Asian countries seem to strike the best balance between liking action and inaction, whereas someone from the Mediterranean area of the world are far less likely to have achieved the same balance. This balance between action and inaction is best displayed in Asia, where Labor Day is not observed until May. A two-year-long study involving over 4,000 volunteer participants (age 19 to 30) from 19 countries and looked at the degree to which a culture holds attitudes toward rest and activity. It was led by Dolores Albarracín, Ph.D., the Martin ...

LEGATO at the 6th International ESP Conference

2013-09-03

On August 28th the LEGATO project team held a successful workshop on rice ecosystem services and ecological engineering at the 6th Annual International Conference of the Ecosystem Services Partnership (ESP) in Bali, Indonesia. The session titled "Rice Ecosystem Services" illustrated the conference motto "Making Ecosystem Services Count!" by presenting the interlinkage of different dimensions of ecosystem service research in LEGATO and collaborating projects, from water management and pollution, via the role of bio-indicator species, in particular of dragonflies (to signalise ...

JCI early table of contents for Sept. 3, 2013

2013-09-03

Enhanced luminal breast tumor response to antiestrogen therapy Breast cancer can be divided into 4 major subtypes using molecular and genetic information from the tumors. Each subtype is associated with different prognosis and should be taken into consideration when making treatment decisions. In this issue of the Journal of Clinical Investigation, Rebecca Cook and colleagues at Vanderbilt University, found that expression of an oncogene, ERBB3, was enhanced in luminal breast cancers compared to other breast cancer subtypes. Addition of the ERBB3 protein to cultured ...

Enhanced luminal breast tumor response to antiestrogen therapy

2013-09-03

Breast cancer can be divided into 4 major subtypes using molecular and genetic information from the tumors. Each subtype is associated with different prognosis and should be taken into consideration when making treatment decisions. In this issue of the Journal of Clinical Investigation, Rebecca Cook and colleagues at Vanderbilt University, found that expression of an oncogene, ERBB3, was enhanced in luminal breast cancers compared to other breast cancer subtypes. Addition of the ERBB3 protein to cultured luminal breast cancer cells increased the growth of the cells; ...

Peritoneal dialysis as an intervention for stroke patients

2013-09-03

Ischemic stroke is characterized by an interruption of the blood supply to the brain, which can lead to brain damage and even death. Excess amounts of the excitatory neurotransmitter glutamate are released during stroke events and further exacerbate brain cell death. Currently, there are no effective strategies for combatting the effects ischemic stroke. In this issue of the Journal of Clinical Investigation , José Sánchez-Prieto and colleagues at the Universidad Complutense demonstrate that peritoneal dialysis is an effective treatment for reducing glutamate levels ...

Added benefit of lisdexamfetamine is not proven

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: